Therapeutic use of hydrogen molecules
AssigneeMax-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
InventorKurt Lucas
Life of this patent
Estimating the term…
Abstract
The invention concerns a kit for preventing or treating oxidative stress in humans or animals by means of therapeutically active hydrogen molecules. The hydrogen molecules are formed by reacting a base metal with aqueous acids or bases and by reacting a saline hydride with water or aqueous acids.
Claims13
A kit for prophylaxis or treatment of oxidative stress in humans and animals, wherein the kit comprises a first component including a base metal for targeted chemical synthesis of therapeutically active hydrogen molecules by reaction with aqueous acid, and a second component, wherein the second component includes at least one acid which is chemically inert with respect to the base metal of the first component, wherein the kit includes adjuvants for an oral form of administration, and wherein the kit includes 0.1 mg to 20 mg magnesium as said base metal, and 1 mg to 1 g of acetylsalicylic acid as said acid in the second component.
A kit for prophylaxis or treatment of oxidative stress in humans and animals using therapeutically active hydrogen molecules, wherein the kit comprising a first component including a base metal for targeted chemical synthesis active hydrogen molecules by reaction with an aqueous base, and a second component includes at least one base which is chemically inert with respect to the base metal of the first component, wherein the kit includes 0.1 mg to 20 mg magnesium as said base metal, and 1 mg to 1 g of said base selected from the group consisting of potassium hydroxide and sodium hydroxide.
Dependencies are inferred from the claim text.